s3-e43.2 - finding the right combinations in nash therapy
Published 2 years ago • 5 plays • Length 12:25Download video MP4
Download video MP3
Similar videos
-
10:57
s3-e43.5 - the future of combination agents in nash therapy
-
1:03:22
s3-e43 - combination agents: a cornerstone of future nash therapy?
-
12:44
s3-e43.4 - optimizing combination agents
-
13:19
s3-e43.3 - science partnerships and nash trials
-
17:37
s3-e54.2 - presentation on efruxifermin in nash with fibrosis
-
1:18:09
s3-e2 - nash-tag 2022 day 1 summary: nash combination therapies, artificial intelligence, basic sci
-
14:25
s3-e17.2 - future targeted nash therapies and nash drug development today
-
20:29
s3-e6 - themes from nash-tag 2022: insights on combination therapies
-
8:04
nafld and clinical significance of grading fibrosis
-
8:26
liver fibrosis: stages and symptoms
-
9:47
fatty liver: what patients need to know
-
31:32
emerging therapies in nash
-
58:54
webinar: evolving diagnostic strategies for nafld/nash
-
25:59
s4-e4.2 - surfing nash community interview with jerry mabary of chronwell
-
0:42
reduce fatty liver by 50 percent!
-
38:02
nash globally: pathways to combination therapy, biomarkers and outcomes | arun sanyal
-
1:03:29
s3-e44 - a preview of paris nash and nafld summit 2022
-
3:32
nonalcoholic steatohepatitis (nash) | upmc on topic
-
58:17
ask the experts: nash and clinical trials
-
21:05
new approaches for nash and nafld
-
6:00
discovering novel genetic targets for fatty liver disease
-
20:43
s3-e38.4 - from the vault: nits & advancing nash therapy at aasld 2021